from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0485/-

LFCtreatmentdescriptionclass of inhibitor

0.140

Amikacinug/mL Amikacintranslation

0.432

Cap5-10ug/mL Capreomycintranslation

1.238

Rox10-50 ug/mL Roxithromycintranslation

0.247

SM2-5 ug/mL Streptomycintranslation

1.184

Tet5-10 ug/mL Tetracyclinetranslation

0.428

Rif0.2-5ug/mL Rifampicintranscription

-0.245

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.363

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.556

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.309

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.511

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.132

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.909

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.918

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.221

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.240

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.498

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.980

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.907

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.055

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.094

KCN5-20 ug/mL Potassium cyaniderespiration

0.690

NaN30.2-2 mM Sodium aziderespiration

-0.218

Nigericin50 uM Nigericinrespiration

0.545

TRC10-150 ug/mL Triclosanrespiration

-0.490

TRZ10-25 ug/mL Thioridazinerespiration

1.292

Valinomycin0.5-10 uM Valinomycinrespiration

-0.532

ZnSO42 mM ZnSO4respiration

1.207

menadione6-10 ug/mL Menadionerespiration

-0.689

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.721

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.133

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.032

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.186

NRP_1Non-replicating persistence stage 1dosRassociated

-0.431

Amp0.2mg/mL AmpicillincellWall

-0.687

Cephalexin20-100 ug/mL CephalexincellWall

-0.353

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.189

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.241

EMB10-20 ug/mL EthambutolcellWall

-0.382

Eta12-40 ug/mL EthionamidecellWall

-0.274

INH0.2-0.4 ug/mL IsoniazidcellWall

0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.529

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.872

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.420

BZA0.12 mg/mL BenzamidearomaticAmides

-1.098

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.625

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.316

H2O24 mM hydrogen peroxideDNAdamaging

-0.506

Levo10 ug/mL LevofloxacinDNAdamaging

0.064

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.249

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.448

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.070

UVUV-irradiationDNAdamaging

3.147

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.420

Antimycin12.5-50 ug/mL Antimycin A?

-0.731

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.240

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.586

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.399

PA8240.2-2 ug/mL PA-824?

1.645

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.018

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.742

Verapamil50 uM Verapamil?

-0.252

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.602

methoxatin10-20 ug/mL Methoxatin?